Related Experiment Videos
Exfoliative dermatitis due to immunologically confirmed carbamazepine hypersensitivity
R J Troost1, A P Oranje, R L Lijnen
1Department of Immunology, Erasmus University, Rotterdam, The Netherlands.
Pediatric Dermatology
|July 1, 1996
Summary
A 6-year-old girl developed a severe skin rash, fever, and swollen lymph nodes while taking carbamazepine. Testing confirmed allergic reactions to the anticonvulsant medication.
Area of Science:
- Dermatology
- Clinical Immunology
- Pharmacology
Background:
- Carbamazepine is a widely used anticonvulsant medication.
- Adverse drug reactions, including severe cutaneous adverse reactions (SCARs), can occur during carbamazepine therapy.
- Early identification and characterization of drug-induced hypersensitivity are crucial for patient management.
Observation:
- A 6-year-old Caucasian female presented with a generalized erythematous skin rash during carbamazepine treatment.
- The rash progressed to erythroderma over four days, accompanied by fever and generalized lymphadenopathy.
- Laboratory findings included elevated liver enzymes and eosinophilia.
Findings:
- Immunologic investigation revealed hypersensitivity to carbamazepine and its analogs.
- In vivo patch testing and in vitro lymphocyte proliferation assays confirmed carbamazepine-induced immune reactivity.
- The findings suggest a drug-induced hypersensitivity syndrome.
Implications:
- This case highlights the importance of considering carbamazepine hypersensitivity in patients presenting with severe skin reactions and systemic symptoms.
- Diagnostic immunologic testing can aid in confirming drug-induced hypersensitivity.
- Awareness of potential carbamazepine adverse effects is critical for clinicians prescribing this medication.